SXC experienced a dramatic financial deterioration with a $140M swing from profitability to significant losses, coupled with a substantial cash burn and debt increase.
The company swung from $95.9M net income to -$44.2M loss while operating cash flow declined 35%, indicating severe operational challenges. The simultaneous 53% cash depletion and 39% debt increase suggests potential liquidity stress and increased financial risk for investors.
SXC experienced a dramatic financial deterioration across all key metrics, with the company swinging from $95.9M net income to -$44.2M losses while operating income turned negative at -$44.4M. The balance sheet weakened significantly as cash declined 53% to $88.7M while debt surged 39% to $685.5M, creating a concerning liquidity profile. Combined with a 35% decline in operating cash flow and rising SG&A expenses, the overall picture signals serious operational challenges and increased financial distress that warrants immediate investor attention.
Net income declined 146.1% — review whether driven by operations, interest costs, or non-recurring items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Cash declined 53.2% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Debt increased 39.2% — substantial leverage increase; assess whether deployed for growth or covering losses.
SG&A up 38.6% — significant increase in sales or administrative costs, monitor impact on operating leverage.
Operating cash flow fell 35.4% — earnings quality concerns; investigate working capital changes and non-cash items.
Liabilities increased 21.6% — monitor debt-to-equity ratio and interest coverage.
Inventory built 21.6% — monitor whether demand supports this build or if write-downs may follow.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Receivables grew 15.4% — monitor days sales outstanding for collection efficiency.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →